leisure time -WSS

leisure time

author：focus 2025-09-30 16:25:29 - browse：267

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： House panel to mark up pandemic

entertainment

WSS

Another man arrested in connection with shooting at Kansas nightclub

Hundreds died while taking an arthritis drug, but nobody alerted patients

Pancreatic cancer is often deadly, but new discoveries are raising hope

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

How redistricting in 6 states could affect who controls Congress

Another man arrested in connection with shooting at Kansas nightclub

knowledge

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

First Opinion on colorectal cancer screening: letter and response

At least 13 dead in Texas as scorching temps continue

Oral obesity drug from Viking Therapeutics hits key early target

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Sen. Bill Cassidy on how to lower drug prices

Tori Bowie and the unacceptable rates of Black maternal death

Alzheimer's risk factor APOE4 may be a distinct form of the disease

knowledge

With fresh data, a dynamic duo powers Eli Lilly to new heights

US intelligence assessment says Iran not currently developing nuclear weapons

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

North Korean leader's powerful sister says warplanes repelled US spy plane

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

entertainment

leisure time

hotspot

entertainment